title: A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia.
authors.affiliation: a Division of Hematology and Hematologic Malignancies , Huntsman Cancer Hospital, The University of Utah , Salt Lake City , UT , USA ;
authors.forename: Srinivas K
authors.initials: SK
authors.lastname: Tantravahi
authors.affiliation: b Department of Pathology , The University of Utah and ARUP Laboratories , Salt Lake City , UT , USA ;
authors.forename: Philippe
authors.initials: P
authors.lastname: Szankasi
authors.affiliation: a Division of Hematology and Hematologic Malignancies , Huntsman Cancer Hospital, The University of Utah , Salt Lake City , UT , USA ;
authors.forename: Jamshid S
authors.initials: JS
authors.lastname: Khorashad
authors.affiliation: c Oregon Health & Science University, Knight Cancer Institute , OR , USA.
authors.forename: Kim-Hien
authors.initials: KH
authors.lastname: Dao
authors.affiliation: a Division of Hematology and Hematologic Malignancies , Huntsman Cancer Hospital, The University of Utah , Salt Lake City , UT , USA ;
authors.forename: Tibor
authors.initials: T
authors.lastname: Kovacsovics
authors.affiliation: b Department of Pathology , The University of Utah and ARUP Laboratories , Salt Lake City , UT , USA ;
authors.forename: Todd W
authors.initials: TW
authors.lastname: Kelley
authors.affiliation: a Division of Hematology and Hematologic Malignancies , Huntsman Cancer Hospital, The University of Utah , Salt Lake City , UT , USA ;
authors.forename: Michael W
authors.initials: MW
authors.lastname: Deininger
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001374:Azacitidine / Q000009:adverse effects / Q000627:therapeutic use*; D054316:Biomarkers, Pharmacological / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D005260:Female; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D054316:Biomarkers, Pharmacological; D014408:Biomarkers, Tumor; D001374:Azacitidine